Key Insights

Highlights

Treatment Research

4 treatments under study, led by Antiinfective Therapy Levofloxacin

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Unknown3

Clinical Trials (3)

Showing 3 of 3 trials
NCT05313750Phase 4UnknownPrimary

Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults

NCT04098094Unknown

Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases

NCT02765295Not ApplicableUnknown

Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study

Showing all 3 trials

Research Network

Common Treatments

  • Antiinfective Therapy Levofloxacin1
  • Medical Ultrasonic Hydrogenoxygen Nebulizer Munho1
  • Antiinfective Therapy Sitafloxacin1
  • Medical Molecular Mesh Oxygen Generator1

Active Sponsors

  • Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil1
  • Shanghai Pulmonary Hospital, Shanghai, China1
  • Guangzhou Institute of Respiratory Disease1

Top Investigators

Related Conditions

  • Interstitial Lung Disease1
  • Acute Exacerbation Of Copd1
  • Neuromuscular Diseases1
  • Bronchiectasis1
  • Acute Exacerbation Of Asthma1

Activity Timeline